CAS: 101328-85-2 - (5R)-6-(4-Aminophenyl)-5-methyl-4,5-dihydro-3(2H)-pyridazinone

Formel: C₁₁H₁₃N₃O

InChl: InChI=1S/C11H13N3O/c1-7-6-10(15)13-14-11(7)8-2-4-9(12)5-3-8/h2-5,7H,6,12H2,1H3,(H,13,15)/t7-/m1/s1

InChI Key: InChIKey=GDMRFHZLKNYRRO-SSDOTTSWSA-N

SMILES: O=C1NN=C(C=2C=CC(N)=CC2)C(C)C1

Synonyme:

• (4R)-3-(4-Aminophenyl)-4-methyl-4,5-dihydro-1H-pyridazin-6-one
• (5R)-6-(4-Aminophenyl)-4,5-dihydro-5-methyl-3(2H)-pyridazinone
• (5R)-6-(4-Aminophenyl)-5-methyl-2,3,4,5-tetrahydropyridazin-3-one
• (5R)-6-(4-Aminophenyl)-5-methyl-4,5-dihydropyridazin-3(2H)-on
• (5R)-6-(4-Aminophenyl)-5-methyl-4,5-dihydropyridazin-3(2H)-one
• (R)-3(2H)Pyridazinone-6-(4-aminophenyl)-4,5-dihydro-5-methyl
• (R)-6-(4-Aminophenyl)-4,5-Dihydro-5-Methyl-3(2H)-Pyridazinone
• (R)-6-(4-Aminophenyl)-5-methyl-4,5-dihydropyridazin-3(2H)-one
• 3(2H)-Pyridazinone, 6-(4-aminophenyl)-4,5-dihydro-5-methyl-, (R)-
• 3(2H)-pyridazinone, 6-(4-aminophenyl)-4,5-dihydro-5-methyl-, (5R)-
• Or 1855

OR-1855

CAS: 101328-85-2

OR-1855 is an active Levosimendan metabolite, has effect on human myometrial contractility.

• Formel: C₁₁H₁₃N₃O
• Reinheit: 98%
• Molekulargewicht: 203.24

3(2H)-Pyridazinone, 6-(4-aminophenyl)-4,5-dihydro-5-methyl-, (5R)-

CAS: 101328-85-2

• Formel: C₁₁H₁₃N₃O
• Reinheit: 95%
• Farbe und Form: Solid
• Molekulargewicht: 203.2404

Levosimendan Impurity 6

CAS: 101328-85-2

• Formel: C₁₁H₁₃N₃O
• Farbe und Form: Pale Yellow Brown Solid
• Molekulargewicht: 203.25

(R)-6-(4-Aminophenyl)-4,5-dihydro-5-methyl-3(2H)-pyridazinone

CAS: 101328-85-2

Applications A metabolite of Levosimendan. References Rubinstein, A., et al.: J. Pharmacol. Met., 19, 213 …

• Formel: C₁₁H₁₃N₃O
• Farbe und Form: Neat
• Molekulargewicht: 203.24

(R)-6-(4-Aminophenyl)-4,5-dihydro-5-methyl-3(2H)-pyridazinone

CAS: 101328-85-2

(R)-6-(4-Aminophenyl)-4,5-dihydro-5-methyl-3(2H)-pyridazinone is an alkalizing agent that is used to treat gout. It is also a …

• Formel: C₁₁H₁₃N₃O
• Reinheit: Min. 95%
• Molekulargewicht: 203.24 g/mol